Dr Elijah Behr

Consultant Cardiologist

MA Cantab MBBS MD

Specialty Cardiology

Special interests Sudden arrhythmic death syndrome, arrhythmia, genetics, drug-induced arrhythmia, long QT syndrome, Brugada syndrome, cardiomyopathy, early repolarisation, electrocardiology, electrophysiology.

Where he works

Get in touch

About

  • Biography icon plus

    Dr Elijah Behr is a Senior lecturer at St George’s, University of London and an Honorary consultant cardiologist at St George’s Hospital, specialising in cardiac electrophysiology. He was appointed in 2007 having undertaken full-time clinical training at St George’s. His undergraduate medical education was completed at St John’s College, University of Cambridge and Guy’s Hospital, London.

    Dr Behr's clinical and research interest is in sudden death and its genetic, clinical, epidemiological and pathological investigation. His aim is to develop novel approaches to risk stratification and prevention. This interest first developed at St George's, University of London in 1999 where he studied victims of unexplained sudden death (the Sudden Arrhythmic Death Syndrome [SADS]) and their families. He is considered an expert in this area and has promoted improvement in patient services and pathways as part of chapter 8 of the National Service Framework. SADS research now focuses on the role for molecular autopsy in diagnostics and novel gene discovery utilising next generation sequencing. His interests also extend to novel genetic, electrophysiological and structural markers for diagnosis and risk stratification of monogenic cardiac diseases such as the long QT and Brugada syndromes and cardiomyopathies including ARVC.

    Dr Behr's other early focus has been the genetic predisposition towards drug-induced arrhythmia, specifically drug-induced Torsades de Pointes (DiTDP). He developed, with John Camm, the British Heart Foundation (BHF) special project grant, the Drug-Induced Risk Evaluation (DARE) study. He has subsequently led DARE’s collaborations with the international Serious Adverse Events Consortium (iSAEC) and as part of the ARITMO consortium (EU FP7). He is also co-chair of the iSAEC sponsored Phenotype Standardisation Project for DiTDP, an international group to promote further genetic studies.

    Dr Behr aslo holds expanded interests in genetic risk of sudden death in sudden infant death syndrome (SIDS), the general population and acquired disease groups utilising large cohort collaborations.

  • Clinical interests icon plus

    Sudden arrhythmic death syndrome, arrhythmia, genetics, drug-induced arrhythmia, long QT syndrome, Brugada syndrome, cardiomyopathy, early repolarisation, electrocardiology, electrophysiology.

back to top